Login
$CRSP
$40.61 +$0.24 (0.59%) After hours

Company Executives

Officer Age In this role Source
Samarth Kulkarni, Ph.D. Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 26, 2026
47 Not stated
Andrew J. Silver
Chief Financial Officer
Title from the Form 4 dated Oct 26, 2026
Not stated Not stated
James R. Kasinger
General Counsel and Secretary
54 Since 2017
9 years
Naimish Patel
Chief Medical Officer
54 Since 2024
2 years
Sivakesava Sakhamuri
Chief Technical Officer
Title from the Form 4 dated Nov 4, 2026
Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
8 of 8
stated in the proxy; 3 not stated
Average tenure
5.8 years
from year joined
CEO also chairs the board
Yes
Samarth Kulkarni, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Samarth Kulkarni, Ph.D.
47 2018
8 years
Not stated None stated Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) Paid as CEO
Douglas A. Treco, Ph.D.
68 2020
6 years
Independent
Audit Committee Nominating Committee · Chair
None stated $370,740
Ali Behbahani, M.D.
49 2015
11 years
Independent
Compensation Committee Nominating Committee
Nkarta, Inc. (Nasdaq: NKTX) $348,240
Maria Fardis, Ph.D.
58 2022
4 years
Independent
Audit Committee
None stated $349,715
H. Edward Fleming, Jr., M.D.
63 2021
5 years
Independent
Compensation Committee
Upstream Bio, Inc. (Nasdaq: UPB) $343,354
Simeon J. George, M.D.
49 2015
11 years
Not stated None stated Nkarta, Inc. (Nasdaq: NKTX) $342,168
John T. Greene
60 2019
7 years
Independent
Audit Committee · Chair Compensation Committee
None stated $363,917
Katherine A. High, M.D.
74 2019
7 years
Independent
Nominating Committee
Incyte Corporation (Nasdaq: INCY) $358,123
Sandesh Mahatme, LL.M.
61 2024
2 years
Independent None stated Idorsia Pharmaceuticals Ltd. (SIX: IDIA) $353,127
Briggs W. Morrison, M.D.
67 2025
1 year
Independent
Compensation Committee · Chair
Arvinas Holding Company, LLC (Nasdaq: ARVN) $341,069
Christian Rommel, Ph.D.
59 2024
2 years
Not stated None stated None stated $335,740

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support